Conditional Licensing and Cannabis Retail in NYS, CWCBExpo Seminar, June 1 2023

February 2024 Regional News Update: Milestones, Projections, and Partnerships

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

 

As February unfolds, the Northeast cannabis industry surges ahead. The landscape continues to shift in New York, with more than 100 new licenses marking a significant stride toward expanding the state’s market. Next door, New Jersey is expected to eclipse $1 billion in sales this year, breaking new ground for the Garden State’s cannabis industry. Meanwhile, in Pennsylvania, Gov. Josh Shapiro (D) has called for legalization, igniting conversations about the state’s potential entry into the adult-use market. Join us as we navigate through the latest milestones, regulatory advancements, and innovative proposals throughout the region.  

 

New York CCB approves over 100 new licenses 

 

The New York State Cannabis Control Board (CCB) made a milestone decision to approve 109 new licenses in the state. Notably, these are the first non-conditional licenses the state will issue, departing from the previous criteria under the Conditional Adult-Use Retail Dispensary (CAURD) program, which prioritized justice-involved individuals. Among these licenses, 38 are allocated for new retail dispensary ventures, while an additional 26 are designated for microbusiness operations, which vertically integrated cultivation, processing, distribution, and retail operations under one license.

 

 “Adult-use cannabis is a growing industry in New York that will help local economies across the state,” Gov. Kathy Hochul (D) said. “The approval of over 100 licenses is a good start and provides individuals with the opportunity to apply for licensing to help drive up local economies around them.”

 

The surge in licensing represents a substantial increase from previous numbers, nearly tripling the number of licenses since December. New York is now home to 70 licensed adult-use dispensaries, with more establishments poised to open soon. 

 

New Jersey sales predicted to surpass $1 billion in 2024

 

Jeff Brown, the executive director of the New Jersey Cannabis Regulatory Commission (NJ-CRC), is bullish on the state’s cannabis industry, projecting that 2024 will be the year when New Jersey exceeds the milestone of $1 billion in annual sales. 

 

Speaking at a public hearing, Brown emphasized the forthcoming regulations aimed at the expansion of edible offerings in the state, highlighting that these regulations would not only enhance consumer safety but also incorporate Good Manufacturing Practices (GMP) provisions to align with federal legalization bills. 

 

“It’s something that will set New Jersey’s market up to compete in decades to come,” Brown said during the hearing. “I’m not counting on federal legalization happening anytime soon, but nonetheless we want to make sure businesses in New Jersey are prepared to compete whenever that opportunity arises.”

 

Brooklyn Nets and New York Liberty partner with CBD company 

 

The Brooklyn Nets and the New York Liberty have made headlines by becoming the first professional basketball teams of the NBA and WNBA to join forces with a CBD company. Mynd Drinks, a hemp-based CBD sparkling beverages company, is set to collaborate with the iconic New York teams following the NBA’s decision to remove cannabis from its list of banned substances for players. 

 

“This gives us an anchor for the East Coast in terms of exposure, marketing, and expansion,” Mynd Drinks CEO Simon Allen said in a statement. “We’ve had tons of opportunities to work with different teams but what we really liked about both of the teams was they shared a lot of what our vision was.”

 

While specific details of the agreements are not all made public, reports state that Mynd Drinks will be available for purchase at all Nets and Liberty games. The company will also sponsor Liberty theme nights throughout the season. 

 

Pennsylvania governor pushes for cannabis legalization 

 

Pennsylvania Gov. Josh Shapiro (D) is urging state officials to seize bipartisan momentum and push forward with the legalization of cannabis in recent statements. Shapiro underscored the urgency of the matter, emphasizing that Pennsylvania’s neighboring states, including Ohio, have already embraced legalization, leaving the Keystone State at a competitive disadvantage. 

 

With an estimated loss of $250 million annually in potential revenue, the governor emphasized the tangible benefits of legalization, highlighting its potential to bolster economic development and fund crucial sectors such as education. 

 

“The reality is, as long as we have safeguards in place to make sure our children aren’t getting their hands on it — it’s just like, we don’t want our kids out drinking, right?” he said. “And a lot of that is going to be a burden on parents and schools and others to make sure we educate on that. Then I think this is something we’ve got to compete on.”

 

In a separate conversation WILK News Radio, Shapiro added that he’s personally “evolved on” the issue and wants a legal cannabis market rooted in the state. “[We are] focused on lifting up Pennsylvania businesses in the process — not these big national conglomerates — and we’re empowering people in local communities to it that I think some good can come from it.”

 

These statements come shortly after the governor included cannabis in his $48.3 billion budget proposal, calling for a 20% excise tax on legal cannabis and estimating that an adult-use cannabis industry in the state could bring in $14.8 million in tax revenue in its first year. Those new dollars would help pay for additional spending on public transit, economic development, housing, and health care, among other priorities.

 

Navigating the green together 

 

Adapting to the dynamic and evolving landscape of cannabis in the Northeast is essential for staying informed and ahead of the curve. Whether you’re a stakeholder, entrepreneur, or enthusiast, CWCBExpo ensures you have the insight and resources to navigate this burgeoning industry successfully. Subscribe to our newsletter or follow us on social media to stay updated and engaged with the latest developments shaping the future of cannabis in the Northeast and beyond. 

8 Cannabis Statistics, Sales Trends, and Projections for 2024

In the fast-paced, constantly evolving, never-stop-to-rest cannabis industry, there’s a palpable sense that things are growing — but sometimes it can be hard to tell exactly how or in what way. In those moments, it can be helpful to pause, take a breath, and review the data.

Whether you’re planning for the future of your cannabis business or trying to better understand your target customers, data can be a helpful tool but also a tricky thing to parse. To help you, Cannabis World Congress and Business Expo (CWCBExpo) has curated this list of important cannabis statistics, trends, and projections you should be aware of as you grow your cannabis business in 2024. The data below was sourced from Equio, New Frontier Data’s cannabis industry database, unless otherwise noted.

1. Consumers still choose flower most, but product types are diversifying

In the U.S., smokeable flower remains the most popular, with around 78 percent of consumers saying they partake in that product type. Edibles are a relatively close second, with 57 percent of consumers opting to eat or drink their cannabis products. Just shy of one-third of cannabis consumers buy disposable vaporizers or vape carts, making this product category a distant third in terms of popularity. Topicals and tinctures appeal to 26 percent of consumers, while extracts and concentrates are chosen by 22 percent.

How do these preferences translate to sales? In December 2023, flower made up 43.56 percent of all cannabis product sales in the U.S., making it the clear leader by a wide margin. Vape products drove the second most sales at 28.3 percent; although only 32 percent of consumers choose vape products, they buy a lot of them quite often. Edibles drove only 12.36 percent of sales despite their popularity among most consumers.

In terms of money, the average value per transaction is highest when consumers choose flower at $82.31 per transaction. Vape products are a close second at $73.66, and tinctures are neck and neck at $73.52. Extracts follow behind at $69.58, with edibles at $58.36 and topicals at $51.95 per transaction. Pre-rolls generate the smallest average transaction value at $38.04, but they make great impulse purchases to help boost a shopper’s cart size.

2. The American cannabis consumer population is on the rise

As cannabis normalizes and new product types like beverages feel easier for some consumers to embrace, the population of cannabis consumers is growing. An estimated 54 million people in the U.S. identify as cannabis consumers, which is more than 16 percent of the national population. In New York alone, the total addressable market (TAM) consists of more than 3.3 million people, meaning there is a ton of opportunity for cannabis entrepreneurs in the Empire State. In fact, New York joins major markets like California in terms of potential for cannabis businesses.

3. More American adults will have access to legal cannabis than ever before

Thanks to the success legal cannabis has had at the ballot box, there are now 38 states plus Washington D.C. with legal medical cannabis programs of some sort. Out of those states, 18 of them along with the nation’s capital have legalized cannabis for adult use. That means 44 percent of American adults now have access to cannabis for any purpose, while 71 percent have access to medical cannabis. In 2024, these numbers are poised to increase, with states like Pennsylvania, South Dakota, Hawaii, and Florida considering adult-use legalization.

4. More than 7,000 dispensaries are operational in the U.S.

While the majority of these dispensaries are clustered in the west, the number of shops operating on the east coast is growing as the region’s legal cannabis industry catches up with the nation’s pioneering states. In New York, for example, the number of adult use dispensaries is now steadily climbing, surpassing 50 in early 2024 following the lifting of an injunction that suspended the Conditional Adult-Use Retail Dispensary (CAURD) license program and the state opened its doors to large multistate operators (MSOs). 

5. Friday is the most lucrative day for U.S. cannabis dispensaries

Cannabis consumers shop the most on Fridays, during which cannabis retailers generate nearly one-fifth of their weekly revenue as shoppers look to stock up for the weekend. The next busiest day is Thursday, when 15.24% of dispensary revenue is realized, closely followed by Saturday at 15.21%. Sunday is the quietest day of the week, but it still accounts for more than 10 percent of dispensaries’ weekly revenue.

6. The regulated market won’t surpass the unlicensed market — yet

The total legal cannabis market in the U.S. is projected to reach $35.16 billion in 2024, with the adult use market contributing $22.4 billion and the medical market $12.72 billion. The legacy market will remain on top this year by a significant sum at $70.9 billion. That means roughly half of the country’s cannabis market remains unregulated, though that share is projected to fall every year. At the current pace, the regulated market would surpass the legacy market in 2029.

7. The cannabis industry is expected to grow 12.84% through 2029

The legal cannabis industry’s compound annual growth rate (CAGR), a measure of how quickly an industry expands over a certain period of time, is projected to be 12.84% from 2024 to 2029. If those projections are accurate, the total legal market will grow to $62.72 billion in 2029. The adult use market would make up $50.29 billion of that value, with medical cannabis driving the remaining $12.43 billion. Projections suggest the legacy market would still represent a total $56.33 billion in 2029.

8. Global legalization will continue to expand

The world is becoming more cannabis-friendly each year, and that won’t stop in 2024. Currently, there are eight countries that have legalized adult use cannabis and established a framework for adult use sales to begin. Notably, the U.S. is represented as one such country in the graphic below due to a majority of its states supporting adult use sales, even though cannabis remains federally illegal. 

Aside from these countries, five others have legalized adult use cannabis without establishing a framework for sales to begin. An additional 17 countries have established a medical cannabis program, while 41 more have some form of cannabis legalization in limited circumstances. Access is expected to expand as countries that have legalized set up regulatory frameworks for sales to begin and additional countries consider legalization measures, including Thailand, Colombia, and Switzerland.

The future continues to burn bright for cannabis

In cannabis, we’re all used to challenges. However, we persevere because we believe in this industry and this plant, and the data shows that our belief is not misplaced. The trend toward a successful, thriving, global cannabis industry has never been clearer. 

As each of us navigate 2024 and beyond, it’s important to band together, and there’s no better chance to do so than attending the CWCBExpo. Join us June 5 – 6 at the Javits Convention Center in New York City to connect with some of the best and brightest in the world of cannabis and start building the future of the industry together.

Register for CWCBExpo to reserve your spot today!

Loading...
Skip to content
Loading...
Skip to content